awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38361620-0A16AE08-C21E-4F49-B30F-B68A25D23483
Q38361620-0A16AE08-C21E-4F49-B30F-B68A25D23483
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38361620-0A16AE08-C21E-4F49-B30F-B68A25D23483
Treatment of relapsed classical Hodgkin lymphoma in the brentuximab vedotin era.
P2860
Q38361620-0A16AE08-C21E-4F49-B30F-B68A25D23483
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38361620-0A16AE08-C21E-4F49-B30F-B68A25D23483
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
16e9a769d2fd871f2c5fe95383b4c3fe39c50d97
P2860
Brentuximab vedotin combined with donor lymphocyte infusions for early relapse of Hodgkin lymphoma after allogeneic stem-cell transplantation induces tumor-specific immunity and sustained clinical remission.